Skip to content

Assessment of Maxillary Sinus Septum and Its Prevalence in a Sample of Egyptian Population (CBCT)

Assessment of Maxillary Sinus Septum and Its Prevalence in a Sample of Egyptian Population Using 3D CBCT : A Cross-Sectional Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03605394
Enrollment
111
Registered
2018-07-30
Start date
2018-08-31
Completion date
2019-03-31
Last updated
2018-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Maxillary Sinus

Keywords

Maxillary sinus, sinus septa, sinus septum, CBCT

Brief summary

a cross-sectional study to estimate the prevalence of maxillary sinus septum and assessment of it in a sample of Egyptian Population using cone beam computed tomography through retrospective data analysis

Detailed description

Setting and location: 1. The data collection will be obtained from the data base available at the department of Oral and Maxillofacial Radiology, Faculty of Dentistry, Cairo University, Cairo, Egypt. 2. CBCT images will be obtained from Egyptian patients who had CBCT examination as part of their dental examination, diagnosis or treatment planning. Participants: A total sample of 111examined sinus belonging to Egyptian individuals will be included. Variables: 1. Prevalence of maxillary sinus septa. 2. Location of maxillary sinus septa. 3. Orientation of maxillary sinus septa in dentulous & edentulous individual. Data Sources / Measurements: * Retrospective Data collection will be performed after the CBCT images are pooled from the computer database. * All the CBCT examinations will be scanned using CBCT machine (Planmeca promax 3D Mid). * CBCT scans using different fields of view, and different voxel resolutions . * CBCT images will be interpreted by two oral radiologists independently; blinded from demographic data of the patients and from the results of each other. * Each one will evaluate the images separately twice with a period of two weeks between the two reading sessions. * Then inter-observational and intra-observational variability between the observers will be evaluated. Bias: No source of bias. Study Size: The results showed that a total sample size of 111examined sinus will be adequate to detect sinus septum prevalence of 24.6% with an 8% margin of error, a significance level of 5% and a 95% confidence interval. Quantitative Variables: The number of CBCT scans of Egyptian individuals with maxillary sinus septa will be counted to estimate the variations in the Egyptian population. Statistical methods: Data will be analysed using IBM SPSS advanced statistics (Statistical Package for Social Sciences), version 21 (SPSS Inc., Chicago, IL). Numerical data will be described as mean and standard deviation or median and range. Categorical data will be described as numbers and percentages.

Interventions

None listed

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL

Inclusion criteria

* • CBCT scans of partially, fully edentulous and dentulous population.

Exclusion criteria

* • CBCT scans that not displaying all the extension of the lower one third of the maxillary sinus. * Presence of large pathological lesions involving the maxillary sinus or affecting the confines of the sinus floor. * Images exhibiting changes in the morphology of sinus walls due to trauma. * Presence of technical artifacts that make difficult the maxillary sinus evaluation.

Design outcomes

Primary

MeasureTime frameDescription
prevalence of maxillary sinus septain the years 2017-2018-2019Measuring device is CBCT Software on Planmeca Promax 3D Mid,Measuring unit is Percentage

Secondary

MeasureTime frameDescription
Location of maxillary sinus septain the years 2017-2018-2019Measuring device is CBCT Software on Planmeca Promax 3D Mid,Measuring unit is Percentage

Other

MeasureTime frameDescription
Orientation of maxillary sinus septain the years 2017-2018-2019Measuring device is CBCT Software on Planmeca Promax 3D Mid,Measuring unit is Categorical data: * Transverse * Oblique * sagittal

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026